Berlin - Delayed Quote • EUR G1 Therapeutics Inc (G1H.BE) Follow 3.7060 +0.1120 (+3.12%) At close: April 26 at 8:30 PM GMT+2 Comparisons Indicators Technicals Corporate Events Chart Types Aggregated Types Draw Table View List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Date Close Open High Low Volume O H L C Vol AAPL Loading Chart for G1H.BE 1D 5D 1M 3M 6M YTD 1Y 2Y 5Y All Date Range 1 min 1 min 2 mins 3 mins 5 mins 15 mins 30 mins 1 hour 4 hours Recent News: G1H.BE View More All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations G1 Therapeutics, Inc.'s (NASDAQ:GTHX) Shift From Loss To Profit G1 Therapeutics to Release First Quarter 2024 Financial Results and Provide Business Update on May 1, 2024 G1 Therapeutics to Participate in the 23rd Annual Needham Virtual Healthcare Conference G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) G1 Therapeutics, Inc. (NASDAQ:GTHX) Q4 2023 Earnings Call Transcript Q4 2023 G1 Therapeutics Inc Earnings Call G1 Therapeutics (GTHX) Reports Q4 Loss, Tops Revenue Estimates G1 Therapeutics Inc (GTHX) Reports Strong Revenue Growth in 2023 G1 Therapeutics Provides Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights G1 Therapeutics to Participate in the TD Cowen 44th Annual Health Care Conference G1 Therapeutics, Inc.'s (NASDAQ:GTHX) 47% loss last week hit both individual investors who own 60% as well as institutions G1 Therapeutics to Release Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on February 28, 2024
